141 related articles for article (PubMed ID: 38041893)
1. Short-term and long-term efficacy of sublingual immunotherapy in different courses for house dust mite-induced allergic rhinitis.
Yang J; Zheng J; Zhou Y; Qiu Q; Zhan J; Wei X
Am J Otolaryngol; 2024; 45(2):104118. PubMed ID: 38041893
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
Huang HH; Xu C; Liu L; Chai RN
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
[No Abstract] [Full Text] [Related]
3. The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration.
Lin Z; Liu Q; Li T; Chen D; Chen D; Xu R
Int Forum Allergy Rhinol; 2016 Jan; 6(1):82-7. PubMed ID: 26575696
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
5. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
6. The Role of Nasal Endoscopy in Allergic Rhinitis and House Dust Mite Sublingual Immunotherapy.
Liu B; Feng J; Hu S
Int Arch Allergy Immunol; 2021; 182(8):690-696. PubMed ID: 34000723
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
[No Abstract] [Full Text] [Related]
9. Efficacy and safety of sublingual immunotherapy with Dermatophagoides farinae drops in pre-school and school-age children with allergic rhinitis.
Tang LX; Yang XJ; Wang PP; Ge WT; Zhang J; Guo YL; Lu J; Tai J; Zhang YM; Ni X
Allergol Immunopathol (Madr); 2018; 46(2):107-111. PubMed ID: 29331618
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in monosensitized and polysensitized patients with allergic rhinitis].
Chen BY; Long ZM; Huang YJ; Zeng JM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 48(7):549-54. PubMed ID: 24313202
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of sublingual immunotherapy in children and adult patients with allergic rhinitis.
Lin X; Lin H; Wei X; Huang Q
Allergol Immunopathol (Madr); 2017; 45(5):457-462. PubMed ID: 28237130
[TBL] [Abstract][Full Text] [Related]
13. Specific sublingual immunotherapy in children with perennial rhinitis: a systemic review and meta-analysis.
Chen L; Lei L; Cai Y; Li T
Int Forum Allergy Rhinol; 2020 Nov; 10(11):1226-1235. PubMed ID: 32329187
[TBL] [Abstract][Full Text] [Related]
14. House dust mite sublingual immunotherapy in allergic rhinitis.
Cho SW; Han DH; Kim JW; Kim DY; Rhee CS
Immunotherapy; 2018 Jun; 10(7):567-578. PubMed ID: 29562802
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sublingual immunotherapy for house dust mite allergic rhinitis.
Cingi C; Bayar Muluk N; Ulusoy S; Acar M; Şirin S; Çobanoğlu B; Birdane L; Kalaycık Ç; Çakır BÖ; Oğhan F; Aynacı S; Erdoğmuş N; Yıldırım Ö; Şahin E; Bulut F; Aksoy MA; Türe N; Bal C
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3341-6. PubMed ID: 25516223
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
[TBL] [Abstract][Full Text] [Related]
17. The influence of house dust mite sublingual immunotherapy on the TSLP-OX40L signaling pathway in patients with allergic rhinitis.
Meng Q; Liu X; Li P; He L; Xie J; Gao X; Wu X; Su F; Liang Y
Int Forum Allergy Rhinol; 2016 Aug; 6(8):862-70. PubMed ID: 27012942
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Efficacy of Dust Mite Sublingual Immunotherapy in Low-Response Allergic Rhinitis Patients after Dose Increment at 6 Months: A Prospective Study.
Gao Y; Lin X; Ma J; Wei X; Wang Q; Wang M
Int Arch Allergy Immunol; 2020; 181(4):311-319. PubMed ID: 32069460
[TBL] [Abstract][Full Text] [Related]
19. Serum Periostin as a Biomarker for Predicting Clinical Response to House Dust Mite Sublingual Immunotherapy in Allergic Rhinitis.
Hoshino M; Akitsu K; Kubota K; Ohtawa J
J Allergy Clin Immunol Pract; 2021 May; 9(5):1864-1870. PubMed ID: 33290915
[TBL] [Abstract][Full Text] [Related]
20. Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study.
Hamada M; Saeki K; Tanaka I
Allergol Int; 2023 Oct; 72(4):573-579. PubMed ID: 36918306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]